Healthcare & Life Sciences

Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.

Why Latham

Melding Deep Industry Experience with Commercial Insight

Companies operating in the healthcare and life sciences sectors face an increasingly complex transactional, political, and competitive landscape. Latham’s superior grasp of the regulatory regimes and market issues means that clients can adroitly and expeditiously address litigation, mergers and acquisitions, capital raising, regulatory counseling, business restructuring and reorganization, contract negotiations, fraud and abuse compliance, white collar and government investigations, operational matters, and more.

Learn more about Latham’s Healthcare & Life Sciences industry experience.

Awards & Rankings

  • Latham Receives 12 China Business Law Journal Awards - June 14, 2022
  • Latham Honoured With Five EMEA LMG Life Sciences Awards - May 12, 2022
  • Litigation & Trial Department Among Most Honored by The American Lawyer Two Years Running - January 02, 2022
  • Healthcare & Life Sciences Counsel Named Among Top Healthcare Lawyers in California - November 07, 2021
  • Intellectual Property Litigation Practice Honored at National Law Journal’s Professional Excellence Awards - October 24, 2021

Latham has a "strong bench of former government attorneys who field expertise across numerous US departments and offices" and a "dominant presence in qui tam suits and criminal proceedings, as well as frequent involvement in complex transactions, including high-value M&A.”

– Chambers USA 2020


Webcast – FDA Regulatory Updates and 2020 Outlook for Vaping and Cannabis-Derived Substances

Media Coverage

Female Disruptors: Jekkie Kim and Frances Stocks Allen On The Three Things You Need To Shake Up Your IndustryLitigators of the Week: The Latham & Watkins Duo Who Paved the Path for Mallinckrodt to Exit BankruptcyUnited Therapeutics Beats HHS’ Discount-Dodging Claims


Latham & Watkins Advises Mallinckrodt in its Completed Financial and Operational Reorganization Latham Receives 12 China Business Law Journal AwardsLatham Advises Peptone on US$40 Million Series A Financing Round

Thought Leadership

Healthcare & Life Sciences: Drug Pricing DigestHealthcare & Life Sciences: Drug Pricing Digest Healthcare & Life Sciences: Drug Pricing Digest

Webcasts & Podcasts

Podcast – Healthcare & Life Sciences: Who Is The New FDA Commissioner And What Are His Priorities?Telehealth Innovations: Legal Considerations for Digital Health Companies Engaging in Value-Based CareThe Biden Administration’s Regulatory and Enforcement Priorities: A Six-Month Update